000 01565 a2200505 4500
005 20250515111739.0
264 0 _c20080508
008 200805s 0 0 eng d
022 _a1351-0088
024 7 _a10.1677/ERC-07-0251
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCampana, D
245 0 0 _aGastric endocrine tumors type I: treatment with long-acting somatostatin analogs.
_h[electronic resource]
260 _bEndocrine-related cancer
_cMar 2008
300 _a337-42 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aCarcinoid Tumor
_xblood
650 0 4 _aChromogranin A
_xblood
650 0 4 _aChronic Disease
650 0 4 _aEndosonography
650 0 4 _aFemale
650 0 4 _aGastrins
_xblood
650 0 4 _aGastritis, Atrophic
_xblood
650 0 4 _aHumans
650 0 4 _aImmunoenzyme Techniques
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOctreotide
_xtherapeutic use
650 0 4 _aParietal Cells, Gastric
_ximmunology
650 0 4 _aStomach Neoplasms
_xblood
650 0 4 _aTreatment Outcome
700 1 _aNori, F
700 1 _aPezzilli, R
700 1 _aPiscitelli, L
700 1 _aSantini, D
700 1 _aBrocchi, E
700 1 _aCorinaldesi, R
700 1 _aTomassetti, P
773 0 _tEndocrine-related cancer
_gvol. 15
_gno. 1
_gp. 337-42
856 4 0 _uhttps://doi.org/10.1677/ERC-07-0251
_zAvailable from publisher's website
999 _c17813397
_d17813397